Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab

AIM: We previously reported a prospective trial evaluating the safety and efficacy of combining ipilimumab and radiation therapy in patients with metastatic melanoma. Herein, we provide a long-term update on patients with complete response (CR) or partial response (PR). PATIENTS & METHODS: We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Sodji, Quaovi H, Gutkin, Paulina M, Swetter, Susan M, Reddy, Sunil A, Hiniker, Susan M, Knox, Susan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212514/
https://www.ncbi.nlm.nih.gov/pubmed/32399174
http://dx.doi.org/10.2217/mmt-2019-0020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212514/
https://www.ncbi.nlm.nih.gov/pubmed/32399174
http://dx.doi.org/10.2217/mmt-2019-0020

Ejemplares similares